Literature DB >> 12902333

The expression of the thyroid-stimulating hormone (TSH) receptor and the cAMP-dependent protein kinase RII beta regulatory subunit confers TSH-cAMP-dependent growth to mouse fibroblasts.

Antonio Porcellini1, Samantha Messina, Giorgia De Gregorio, Antonio Feliciello, Annalisa Carlucci, Mariavittoria Barone, Antonietta Picascia, Antonio De Blasi, Enrico V Avvedimento.   

Abstract

TSH activates its specific receptor in thyroid cells and induces cAMP, a robust stimulator of thyroid cell proliferation. Conversely, cAMP is a potent inhibitor of growth in mouse fibroblasts. To dissect the signals mediating cAMP-dependent growth, we have expressed in mouse fibroblasts the human thyrotropin receptor (TSHR) or a constitutively active mutant, under the control of the tetracyclin promoter. Both TSHR and cAMP levels were modulated by tetracyclin. In the presence of serum, activation of TSHR by TSH induced growth arrest. In the absence of serum, cells expressing TSHR stimulated with TSH, replicated their DNA, but underwent apoptosis. Co-expression of cAMP-dependent protein kinase (PKA) regulatory subunit type II (RIIbeta) inhibited apoptosis and stimulated the growth of cells only in the presence of TSH. Expression of RIIbeta-PKA, in the absence of TSHR, induced apoptosis, which was reversed by cAMP. Growth, stimulated by TSHR-RIIbeta-PKA in mouse fibroblasts, was also dependent on Rap1 activity, indicating cAMP-dependent growth in thyroid cells. As for the molecular mechanism underlying these effects, we found that in normal fibroblasts, TSH induced AKT and ERK1/2 only in cells expressing TSHR and RII. Similarly, activation of TSHR increased cAMP levels greatly, but was unable to stimulate CREB phosphorylation and transcription of cAMP-induced genes in the absence of RII. These data provide a simple explanation for the anti-proliferative and proliferative effects of cAMP in different cell types and indicate that RII-PKAII complements TSHR action by stably propagating robust cAMP signals in cell compartments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902333     DOI: 10.1074/jbc.M307501200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN.

Authors:  Bin Li; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2014-05-19       Impact factor: 5.958

Review 2.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

3.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

4.  3',5'-cyclic adenosine monophosphate response element binding protein up-regulated cytochrome P450 lanosterol 14alpha-demethylase expression involved in follicle-stimulating hormone-induced mouse oocyte maturation.

Authors:  Gang Ning; Hong Ouyang; Songbo Wang; Xiufen Chen; Baoshan Xu; Jiange Yang; Hua Zhang; Meijia Zhang; Guoliang Xia
Journal:  Mol Endocrinol       Date:  2008-05-08

5.  Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway.

Authors:  Wei-Lin Huang; Zhongyou Li; Ting-Yu Lin; Sheng-Wen Wang; Fang-Ju Wu; Ching-Wei Luo
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

6.  Persistent cAMP-signals triggered by internalized G-protein-coupled receptors.

Authors:  Davide Calebiro; Viacheslav O Nikolaev; Maria Cristina Gagliani; Tiziana de Filippis; Christian Dees; Carlo Tacchetti; Luca Persani; Martin J Lohse
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

7.  Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions.

Authors:  Nupur Raychaudhuri; Roshini Fernando; Terry J Smith
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.